New shot aims to help millions with hardened arteries
Disease control
Not yet recruiting
This study is testing a new injectable drug called SRSD107 for people with chronic coronary artery disease (CAD) or peripheral artery disease (PAD). The main goals are to see how the drug behaves in the body, if it's safe, and how it affects certain blood markers. About 104 parti…
Phase: PHASE2 • Sponsor: Sirius Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC